Could breathing therapy beat chronic fatigue? new trial aims to find out
NCT ID NCT07317401
First seen Jan 06, 2026 · Last updated May 10, 2026 · Updated 15 times
Summary
This study tests a treatment called Intermittent Hypoxia-Hyperoxia Therapy (IHHT) for people with ME/CFS or long COVID who suffer from extreme fatigue, muscle pain, and brain fog. About 87 patients will receive either real IHHT or a placebo over six weeks, while 17 healthy people serve as a comparison group. The goal is to see if this oxygen-based therapy can boost energy and improve quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS) (ICD-10 G93.3) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus University
Aarhus, Region Midt, 8200, Denmark
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.